Probenecid was developed as an alternative to [[caronamide]]<ref name="pmid13171805">{{cite journal |author=MASON RM |title=Studies on the Effect of Probenecid ('Benemid') in Gout |journal=Ann. Rheum. Dis. |volume=13 |issue=2 |pages=120â€“30 |date=June 1954 |pmid=13171805 |pmc=1030399 |doi= 10.1136/ard.13.2.120|url=http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=13171805}}</ref> to competitively inhibit renal excretion of some drugs, thereby increasing their plasma concentration and prolonging their effects.
